Aileron Therapeutics Inc (NASDAQ:ALRN)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ALRN

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ALRN

  • Market Cap$75.760m
  • SymbolNASDAQ:ALRN
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS00887A1051

Company Profile

Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing and commercializing a novel class of therapeutics called stapled peptides. The company's lead product candidate, ALRN-6924, targets the tumor suppressor p53 for the treatment of a wide variety of cancers.Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company that is focused on developing and commercializing a novel class of therapeutics called stapled peptides. The company's lead candidate is ALRN-6924.

Latest ALRN news

Currently there for this company. Visit our news hub for other news .